Bespoke treatment for individual cancers is no longer a dream and is now the primary goal for current research. This book provides an overview of the most recent techniques, agents and approaches for breast cancer and the tailoring of treatment. Particular attention is given to organ-specific tailored approaches and their impact on the "re-classification" of breast cancer. Also addressed is how best to integrate biological markers, new technologies, and new diagnostic and therapeutic approaches into clinical trials and practice. A combination of editorial comment and contributions from experts provide an overview of the latest developments in treating breast cancer and their use in clinical practice. This book is the result of advances in molecular-based medicine and an increasing knowledge of breast cancer molecular biology that is leading to increased survival for cancer patients and an improved quality of life.